Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-025381
Filing Date
2024-10-17
Accepted
2024-10-17 17:06:43
Documents
1
Period of Report
2024-10-15

Document Format Files

Seq Description Document Type Size
1 form4-10172024_091039.html 4  
1 form4-10172024_091039.xml 4 5632
  Complete submission text file 0001415889-24-025381.txt   7098
Mailing Address 5871 OBERLIN DRIVE, SUITE 150 SAN DIEGO CA 92121
Business Address
Heyman Richard A. (Reporting) CIK: 0001584759 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39247 | Film No.: 241378275

Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 720-647-8519
Enliven Therapeutics, Inc. (Issuer) CIK: 0001672619 (see all company filings)

EIN.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)